Literature DB >> 6440473

Regrowth of aminoglycoside-resistant variants and its possible implication for determination of MICs.

L Sörén, L Nilsson.   

Abstract

Regrowth of aminoglycoside-resistant variants was seen when large inocula of two strains of Escherichia coli were incubated with gentamicin in concentrations well above their MICs (0.5 micrograms/ml). The extent of the selection of resistant variants was proportional to the concentration of gentamicin during incubation; after incubation with gentamicin (greater than or equal to 2 micrograms/ml for 24 h), all bacteria were resistant to at least 8 micrograms/ml. Bacteria resistant to these concentrations always formed small colonies, whereas variants resistant to lower concentrations (1 to 2 micrograms/ml) could form both small and normal colonies. The regrowth of resistant variants could be monitored by luciferase assay of intracellular ATP in cultures incubated with gentamicin (less than or equal to 2 micrograms/ml). In cultures incubated with higher concentrations, regrowth did occur, although this did not result in viability (CFU per milliliter) or ATP levels above those of the initial inocula. The implications of this regrowth for MIC determinations in broth and the possible clinical revelance of the resistant variants are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6440473      PMCID: PMC179953          DOI: 10.1128/AAC.26.4.501

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  New rapid bioassay of gentamicin based on luciferase assay of extracellular ATP in bacterial cultures.

Authors:  L Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

2.  Nonspecific aminoglycoside cross-resistance of Serratia marcescens.

Authors:  W H Traub; P I Fukushima
Journal:  Chemotherapy       Date:  1979       Impact factor: 2.544

3.  Small-colony forms of enteric bacteria after exposure to aminoglycosides.

Authors:  M Mowjood; F E Miller; J Schor; F E Kocka
Journal:  Am J Clin Pathol       Date:  1979-07       Impact factor: 2.493

4.  Selection of small-colony variants of Enterobacteriaceae by in vitro exposure to aminoglycosides: pathogenicity for experimental animals.

Authors:  D M Musher; R E Baughn; G L Merrell
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

5.  Pseudomonas aeruginosa bacteremia: susceptibility of 100 blood culture isolates to seven antimicrobial agents and its clinical significance.

Authors:  A L Baltch; M Hammer; R P Smith; N Sutphen
Journal:  J Lab Clin Med       Date:  1979-08

6.  Virulent gentamicin-induced small colony variants of Staphylococcus aureus.

Authors:  L L Pelletier; M Richardson; M Feist
Journal:  J Lab Clin Med       Date:  1979-08

7.  Clinical isolation and characterization of aminoglycoside-resistant small colony variants of Enterobacter aerogenes.

Authors:  J J Rusthoven; T A Davies; S A Lerner
Journal:  Am J Med       Date:  1979-10       Impact factor: 4.965

8.  Aminoglycoside-resistant mutants of Pseudomonas aeruginosa deficient in cytochrome d, nitrite reductase, and aerobic transport.

Authors:  L E Bryan; S Kwan
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

9.  Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice.

Authors:  A U Gerber; W A Craig
Journal:  J Lab Clin Med       Date:  1982-11

10.  Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model.

Authors:  A U Gerber; A P Vastola; J Brandel; W A Craig
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.